Is Surgepays Stock a Good Investment?
Surgepays Investment Advice | SURG |
- Examine Surgepays' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Surgepays' leadership team and their track record. Good management can help Surgepays navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Wireless Telecommunication Services space and any emerging trends that could impact Surgepays' business and its evolving consumer preferences.
- Compare Surgepays' performance and market position to its competitors. Analyze how Surgepays is positioned in terms of product offerings, innovation, and market share.
- Check if Surgepays pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Surgepays' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Surgepays stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Surgepays is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Examine Surgepays Stock
Researching Surgepays' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 32.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.06. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Surgepays has Price/Earnings To Growth (PEG) ratio of 0.53. The entity recorded a loss per share of 1.18. The firm had not issued any dividends in recent years. Surgepays had 1:50 split on the 2nd of November 2021.
To determine if Surgepays is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Surgepays' research are outlined below:
| Surgepays had very high historical volatility over the last 90 days | |
| Surgepays may become a speculative penny stock | |
| About 32.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from bizjournals.com: Memphis-area company announces multiyear deal with ATT |
Surgepays Quarterly Cash And Short Term Investments |
|
Surgepays uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Surgepays. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Surgepays' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Earnings surprises can significantly impact Surgepays' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Surgepays' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2015-06-30 | 2015-06-30 | 0.04 | 0.05 | 0.01 | 25 | ||
2014-12-31 | 2014-12-31 | 0.02 | 0.03 | 0.01 | 50 | ||
2014-09-30 | 2014-09-30 | 0.02 | 0.03 | 0.01 | 50 | ||
2015-03-31 | 2015-03-31 | 0.02 | 0.04 | 0.02 | 100 | ||
2022-05-16 | 2022-03-31 | -0.04 | -0.1 | -0.06 | 150 | ||
2024-05-13 | 2024-03-31 | 0.15 | 0.07 | -0.08 | 53 | ||
2022-08-11 | 2022-06-30 | 0.01 | -0.07 | -0.08 | 800 | ||
2024-03-12 | 2023-12-31 | 0.41 | 0.2 | -0.21 | 51 |
Know Surgepays' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Surgepays is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Surgepays backward and forwards among themselves. Surgepays' institutional investor refers to the entity that pools money to purchase Surgepays' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Royal Bank Of Canada | 2024-06-30 | 26.2 K | Corsair Capital Management Llc | 2024-06-30 | 19.9 K | Royce & Associates, Lp | 2024-09-30 | 18.6 K | Simplex Trading, Llc | 2024-06-30 | 17.5 K | Advisor Group Holdings, Inc. | 2024-06-30 | 16.6 K | Ubs Group Ag | 2024-06-30 | 14.1 K | James Investment Research, Inc. | 2024-09-30 | 13 K | Goss Wealth Management Llc | 2024-06-30 | 13 K | Cetera Investment Advisers | 2024-06-30 | 12.2 K | Vanguard Group Inc | 2024-09-30 | 587 K | Cable Car Capital Llc | 2024-09-30 | 515 K |
Surgepays' market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 35.28 M.Market Cap |
|
Surgepays' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.55 | 0.58 | |
| Return On Capital Employed | 0.65 | 0.68 | |
| Return On Assets | 0.49 | 0.52 | |
| Return On Equity | 0.73 | 0.69 |
Determining Surgepays' profitability involves analyzing its financial statements and using various financial metrics to determine if Surgepays is a good buy. For example, gross profit margin measures Surgepays' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Surgepays' profitability and make more informed investment decisions.
Evaluate Surgepays' management efficiency
Surgepays has return on total asset (ROA) of (0.0151) % which means that it has lost $0.0151 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0519) %, meaning that it created substantial loss on money invested by shareholders. Surgepays' management efficiency ratios could be used to measure how well Surgepays manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Surgepays' Return On Assets are most likely to increase significantly in the upcoming years. At this time, Surgepays' Non Current Assets Total are most likely to increase significantly in the upcoming years. The Surgepays' current Non Currrent Assets Other is estimated to increase to about 3 M, while Intangible Assets are projected to decrease to roughly 2 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.99 | 3.96 | |
| Tangible Book Value Per Share | 1.69 | 3.06 | |
| Enterprise Value Over EBITDA | 4.12 | 4.33 | |
| Price Book Value Ratio | 3.26 | 3.42 | |
| Enterprise Value Multiple | 4.12 | 4.33 | |
| Price Fair Value | 3.26 | 3.42 | |
| Enterprise Value | 82.8 M | 86.9 M |
The strategic initiatives led by Surgepays' management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Beta 1.392 |
Basic technical analysis of Surgepays Stock
As of the 25th of November, Surgepays has the Semi Deviation of 5.03, risk adjusted performance of 0.0137, and Coefficient Of Variation of 15186.45. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Surgepays, as well as the relationship between them. Please validate Surgepays information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Surgepays is priced more or less accurately, providing market reflects its prevalent price of 1.75 per share. Please also confirm Surgepays total risk alpha, which is currently at (0.89) to double-check the company can sustain itself at a future point.Surgepays' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Surgepays insiders, such as employees or executives, is commonly permitted as long as it does not rely on Surgepays' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Surgepays insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Surgepays' Outstanding Corporate Bonds
Surgepays issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Surgepays uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Surgepays bonds can be classified according to their maturity, which is the date when Surgepays has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View |
Understand Surgepays' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Surgepays' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0137 | |||
| Market Risk Adjusted Performance | 0.0239 | |||
| Mean Deviation | 4.1 | |||
| Semi Deviation | 5.03 | |||
| Downside Deviation | 5.19 | |||
| Coefficient Of Variation | 15186.45 | |||
| Standard Deviation | 5.86 | |||
| Variance | 34.37 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.89) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0139 | |||
| Maximum Drawdown | 25.51 | |||
| Value At Risk | (8.74) | |||
| Potential Upside | 10.26 | |||
| Downside Variance | 26.97 | |||
| Semi Variance | 25.29 | |||
| Expected Short fall | (4.27) | |||
| Skewness | 1.17 | |||
| Kurtosis | 3.51 |
| Risk Adjusted Performance | 0.0137 | |||
| Market Risk Adjusted Performance | 0.0239 | |||
| Mean Deviation | 4.1 | |||
| Semi Deviation | 5.03 | |||
| Downside Deviation | 5.19 | |||
| Coefficient Of Variation | 15186.45 | |||
| Standard Deviation | 5.86 | |||
| Variance | 34.37 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.89) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0139 | |||
| Maximum Drawdown | 25.51 | |||
| Value At Risk | (8.74) | |||
| Potential Upside | 10.26 | |||
| Downside Variance | 26.97 | |||
| Semi Variance | 25.29 | |||
| Expected Short fall | (4.27) | |||
| Skewness | 1.17 | |||
| Kurtosis | 3.51 |
Consider Surgepays' intraday indicators
Surgepays intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Surgepays stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Surgepays time-series forecasting models is one of many Surgepays' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Surgepays' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Surgepays Stock media impact
Far too much social signal, news, headlines, and media speculation about Surgepays that are available to investors today. That information is available publicly through Surgepays media outlets and privately through word of mouth or via Surgepays internal channels. However, regardless of the origin, that massive amount of Surgepays data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Surgepays news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Surgepays relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Surgepays' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Surgepays alpha.
Surgepays Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Surgepays can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Surgepays Corporate Management
| Carter Matzinger | Chief LogicsIQ | Profile | |
| CPA CIA | CFO COO | Profile | |
| John Mott | Chief Officer | Profile | |
| Brian CFA | Managing MZ | Profile | |
| MBA JD | Secretary Services | Profile | |
| Jeremy Gies | I Fintech | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Wireless Telecommunication Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgepays. If investors know Surgepays will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgepays listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.78) | Earnings Share (1.18) | Revenue Per Share 6.864 | Quarterly Revenue Growth (0.58) | Return On Assets (0.02) |
The market value of Surgepays is measured differently than its book value, which is the value of Surgepays that is recorded on the company's balance sheet. Investors also form their own opinion of Surgepays' value that differs from its market value or its book value, called intrinsic value, which is Surgepays' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgepays' market value can be influenced by many factors that don't directly affect Surgepays' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Surgepays' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Surgepays is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgepays' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.